These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 31816725)
1. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring. Koller D; Vaitsekhovich V; Mba C; Steegmann JL; Zubiaur P; Abad-Santos F; Wojnicz A Talanta; 2020 Feb; 208():120450. PubMed ID: 31816725 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation. Koller D; Zubiaur P; Saiz-Rodríguez M; Abad-Santos F; Wojnicz A Talanta; 2019 Jun; 198():159-168. PubMed ID: 30876545 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring. Wojnicz A; Colom-Fernández B; Steegmann JL; Muñoz-Calleja C; Abad-Santos F; Ruiz-Nuño A Ther Drug Monit; 2017 Jun; 39(3):252-262. PubMed ID: 28490048 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous and rapid determination of 12 tyrosine kinase inhibitors by LC-MS/MS in human plasma: Application to therapeutic drug monitoring in patients with non-small cell lung cancer. Zhou L; Wang S; Chen M; Huang S; Zhang M; Bao W; Bao A; Zhang P; Guo H; Liu Z; Xie G; Gao J; Wu Z; Lou Y; Fan G J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1175():122752. PubMed ID: 33991955 [TBL] [Abstract][Full Text] [Related]
5. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method. Verougstraete N; Stove V; Verstraete AG; Stove C Talanta; 2021 May; 226():122140. PubMed ID: 33676691 [TBL] [Abstract][Full Text] [Related]
6. Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies. Wojnicz A; Belmonte C; Koller D; Ruiz-Nuño A; Román M; Ochoa D; Abad-Santos F J Pharm Biomed Anal; 2018 Mar; 151():116-125. PubMed ID: 29324280 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of three tyrosine kinase inhibitors and three triazoles in human plasma by LC-MS/MS: applications to therapeutic drug monitoring and drug-drug interaction studies. Li N; Liu L; Liu D; Yu H; Yang G; Qiu L; Chen Y; Xiang D; Gong X J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Oct; 1246():124276. PubMed ID: 39208604 [TBL] [Abstract][Full Text] [Related]
9. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring. Zhang M; Liu X; Chen Z; Jiang S; Wang L; Tao M; Miao L J Pharm Biomed Anal; 2022 Mar; 211():114562. PubMed ID: 35124453 [TBL] [Abstract][Full Text] [Related]
10. High-throughput liquid chromatography/electrospray ionization-tandem mass spectrometry method using in-source collision-induced dissociation for simultaneous quantification of imatinib, dasatinib, bosutinib, nilotinib, and ibrutinib in human plasma. Hirasawa T; Kikuchi M; Shigeta K; Takasaki S; Sato Y; Sato T; Ogura J; Onodera K; Fukuhara N; Onishi Y; Maekawa M; Mano N Biomed Chromatogr; 2021 Aug; 35(8):e5124. PubMed ID: 33772839 [TBL] [Abstract][Full Text] [Related]
11. Novel high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification of BCR-ABL and Bruton's tyrosine kinase inhibitors and their three active metabolites in human plasma. Mukai Y; Yoshida T; Kondo T; Inotsume N; Toda T J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1137():121928. PubMed ID: 31877431 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma. Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133 [TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Simultaneous Quantification Method of 14 Tyrosine Kinase Inhibitors in Human Plasma Using LC-MS/MS. Huynh HH; Pressiat C; Sauvageon H; Madelaine I; Maslanka P; Lebbé C; Thieblemont C; Goldwirt L; Mourah S Ther Drug Monit; 2017 Feb; 39(1):43-54. PubMed ID: 27861317 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies. Maher HM; Alzoman NZ; Shehata SM J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895 [TBL] [Abstract][Full Text] [Related]
15. An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry. Couchman L; Birch M; Ireland R; Corrigan A; Wickramasinghe S; Josephs D; Spicer J; Flanagan RJ Anal Bioanal Chem; 2012 Jun; 403(6):1685-95. PubMed ID: 22526649 [TBL] [Abstract][Full Text] [Related]
16. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring. Llopis B; Robidou P; Tissot N; Pinna B; Gougis P; Aubart FC; Campedel L; Abbar B; Weil DR; Uzunov M; Gligorov J; Salem JE; Funck-Brentano C; Zahr N J Pharm Biomed Anal; 2021 Apr; 197():113968. PubMed ID: 33618135 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous Quantification of BCR-ABL and Bruton Tyrosine Kinase Inhibitors in Dried Plasma Spots and Its Application to Clinical Sample Analysis. Mukai Y; Yoshida Y; Yoshida T; Kondo T; Inotsume N; Toda T Ther Drug Monit; 2021 Jun; 43(3):386-393. PubMed ID: 33065614 [TBL] [Abstract][Full Text] [Related]
18. Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma. Vrobel I; Janečková H; Faber E; Bouchalová K; Mičová K; Friedecký D; Adam T Ther Drug Monit; 2016 Aug; 38(4):516-24. PubMed ID: 27414975 [TBL] [Abstract][Full Text] [Related]
19. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring. Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342 [TBL] [Abstract][Full Text] [Related]
20. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma. Xue YJ; Akinsanya JB; Liu J; Unger SE Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]